CesarMartinCastroMDMMSc

Summary

• Cesar M. Castro, MD, MMSc is currently an Associate Professor of Medicine at Harvard Medical School and Director of the Gynecologic Oncology Program at the MGH Cancer Center. Dr. Castro is a translational oncologist with experience leveraging nanotechnology and molecular imaging for solid tumor detection and serial profiling. He also directs the Cancer Program within the MGH Center for Systems Biology. He is Chair of the Mass General Brigham Phase 1 Cancer Clinical Trials. Dr. Castro serves on the steering committee for the National Cancer Institute Liquid Biopsy Consortium. He is also a standing member and alternate Chair of the NIH Innovations in Nanotechnology and Nanosystems Study Section.
  
  Dr. Castro graduated from the University of California, Berkeley and received his medical degree from the UCSF School of Medicine where he also completed his Internal Medicine residency training. Dr. Castro completed an adult oncology fellowship from the Dana-Farber / Mass General Brigham Cancer Care program. During this period, he received a MMSc from Harvard Medical School. Dr. Castro has received funding as principal investigator from the National Institutes of Health (R01, U01, P50), Department of Defense, Robert Wood Johnson Foundation, and the Ovarian Cancer Research Fund, among various other sources.